ADRIANA JENKINS: Open Payments
NPI 1255988580 · PHILADELPHIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 60 payments from 14 companies in 2025. Trend: 2023 $675 · 2024 $426 · 2025 $865
Food & beverage: $795Education: $70
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $142 |
| HARMONY BIOSCIENCES LLC | 2 | $102 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, COBENFY, Auvelity, INGREZZA, SPRAVATO, Jornay PM.
Industry payments across MS — which companies pay providers there.
